Non-alcoholic fatty liver disease gets a rebrand

By Axios
| May 06, 2024

Experts say the name was changed to metabolic dysfunction-associated steatotic liver disease, or MASLD, to more accurately reflect the science of the condition as a metabolic disorder.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...